Literature DB >> 18035039

Structure-based interpretation of the mutagenesis database for the nucleotide binding domains of P-glycoprotein.

J Lawson1, M L O'Mara, I D Kerr.   

Abstract

P-glycoprotein (P-gp) is the most intensively studied eukaryotic ATP binding cassette (ABC) transporter, due to its involvement in the multidrug resistance phenotype of a number of cancers. In common with most ABC transporters, P-gp is comprised of two transmembrane domains (TMDs) and two nucleotide binding domains (NBD), the latter coupling ATP hydrolysis with substrate transport (efflux in the case of P-gp). Biochemical investigations over the past twenty years have attempted to unlock mechanistic aspects of P-glycoprotein through scanning and site-directed mutagenesis of both the TMDs and the NBDs. Contemporaneously, crystallographers have elucidated the atomic structure of numerous ABC transporter NBDs, as well as the intact structure (i.e. NBDs and TMDs) of a distantly related ABC-exporter Sav1866. Significantly, the structure of P-gp remains unknown, and only low resolution electron microscopy data exists. Within the current manuscript we employ crystallographic data for homologous proteins, and a molecular model for P-gp, to perform a structural interpretation of the existing "mutagenesis database" for P-gp NBDs. Consequently, this will enable testable predictions to be made that will result in further in-roads into our understanding of this clinically important drug pump.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18035039     DOI: 10.1016/j.bbamem.2007.10.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  A novel MDR1 GT1292-3TG (Cys431Leu) genetic variation and its effect on P-glycoprotein biologic functions.

Authors:  Matthew H Crouthamel; Daniel Wu; Ziping Yang; Rodney J Y Ho
Journal:  AAPS J       Date:  2010-07-10       Impact factor: 4.009

2.  Insights Into the Molecular Mechanism of Triptan Transport by P-glycoprotein.

Authors:  Laura A Wilt; Diana Nguyen; Arthur G Roberts
Journal:  J Pharm Sci       Date:  2017-03-07       Impact factor: 3.534

3.  A Conformationally Gated Model of Methadone and Loperamide Transport by P-Glycoprotein.

Authors:  Morgan E Gibbs; Laura A Wilt; Kaitlyn V Ledwitch; Arthur G Roberts
Journal:  J Pharm Sci       Date:  2018-02-28       Impact factor: 3.534

4.  Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.

Authors:  Kaitlyn V Ledwitch; Morgan E Gibbs; Robert W Barnes; Arthur G Roberts
Journal:  Biochem Pharmacol       Date:  2016-08-13       Impact factor: 5.858

5.  Asymmetric switching in a homodimeric ABC transporter: a simulation study.

Authors:  Jussi Aittoniemi; Heidi de Wet; Frances M Ashcroft; Mark S P Sansom
Journal:  PLoS Comput Biol       Date:  2010-04-29       Impact factor: 4.475

6.  Dimerization of ABCG2 analysed by bimolecular fluorescence complementation.

Authors:  Ameena J Haider; Deborah Briggs; Tim J Self; Hannah L Chilvers; Nicholas D Holliday; Ian D Kerr
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

7.  Identification of residues in ABCG2 affecting protein trafficking and drug transport, using co-evolutionary analysis of ABCG sequences.

Authors:  Ameena J Haider; Megan H Cox; Natalie Jones; Alice J Goode; Katherine S Bridge; Kelvin Wong; Deborah Briggs; Ian D Kerr
Journal:  Biosci Rep       Date:  2015-07-17       Impact factor: 3.840

8.  Residues contributing to drug transport by ABCG2 are localised to multiple drug-binding pockets.

Authors:  Megan H Cox; Parth Kapoor; Deborah A Briggs; Ian D Kerr
Journal:  Biochem J       Date:  2018-05-04       Impact factor: 3.857

9.  Molecular models of human P-glycoprotein in two different catalytic states.

Authors:  Jean-Paul Becker; Grégoire Depret; Françoise Van Bambeke; Paul M Tulkens; Martine Prévost
Journal:  BMC Struct Biol       Date:  2009-01-22

10.  Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.

Authors:  Kaitlyn V Ledwitch; Robert W Barnes; Arthur G Roberts
Journal:  Biosci Rep       Date:  2016-01-28       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.